大麻股Tilray Q1業績低於預期 成本節約計劃進行順利 重申年度自由現金流將實現轉正
格隆匯10月7日丨大麻股Tilray第一財季營收1.532億美元,去年同期為1.68億美元,市場預期為1.559億美元;調整後每股虧損8美分,去年同期為每股虧損13美分,市場預期為每股虧損6美分。公司CEO Irwin D. Simon表示:“截至第一財季,我們已經實現了上調後的1億美元的年化成本節約目標中的9500萬美元。此外,我們還從最近為現有的大麻業務啟動的3000萬美元成本優化計劃中實現了額外的1300萬美元的成本節約。總的來説,我們預計將從該業務中去除1.3億美元的成本。我們還計劃從戰略性的HEXO交易中額外實現4000萬美元的營收和利息收入。這些舉措,加上我們市場份額和營收的增加,應該使Tilray在未來有一個非常好的定位,使我們能夠重申調整後EBITDA為7000-8000萬美元並讓自由現金流轉正的的指引。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.